Join Samar Darwish, Director of Regulatory Affairs at Boehringer Ingelheim, and Joe Fargo, Executive Director, Private Markets & Investment Policy at Innovative Medicines Canada in their discussion on the future of Canada’s access to innovative medicines through Health Canada’s modernization plan, pricing and other challenges for drug access, and more.
This event has taken place on Friday, August 20th. You may watch the recorded version below!